tried euflexxa and it worked very well. Insurance will no longer cover it, insurance suggested these: syndics, syndics-one, monovisc or orthovisc wondering which is best
Hyaluronic acid is a naturally occurring substance present in the synovial fluid of your joints. In your knees, synovial fluid, a thick gel-like liquid, helps cushion your joint and absorb the shock of walking, running, twisting, and turning. People with osteoarthritis of the knee have lower levels of hyaluronic acid in their synovial fluid.
Viscosupplements are injections containing hyaluronic acid which are injected into the affected knee in order return some mobility to the joint.
There are several viscosupplements available. Each one is slightly different, but they’re all designed to help people looking to treat the signs and symptoms of OA find relief.
Euflexxa is given as a three-dose injection over three weeks (one injection per week). The average patient may experience relief from a series of Euflexxa injections for six months.
Synvisc also requires three injections of hyaluronic acid. The effects of the injection can last as long as six months.
Synvisc-One and Monovisc are approved as a one-dose injections. The FDA indicates that this viscosupplement is designed to provide up to six months of OA relief after just one injection.
Monovisc and Orthovisc are non-animal sourced hyaluronic acid (the others are derived from rooster combs). This makes them options for OA patients with sensitivities or allergies to birds or chickens, eggs, and feathers. Orthovisc is available as a three- or four-dose injection.
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
My dr wanted to give me the three injections of euflexxa in my shoulder the insurance will not cover
Updated 19 Feb 2015 • 1 answer
What would likely happen if I ran a 4-mile race at an easy pace 30 hours after my third Euflexxa in?
Updated 16 Dec 2014 • 2 answers
Updated 11 Apr 2015 • 1 answer
Updated 20 Oct 2016 • 1 answer
Updated 17 Jan 2017 • 1 answer